NuvoBio Corporation
$30,000.00 CAD
≈ 5 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- September 1, 2024 – October 31, 2025
- Reference
- nrc-cnrc:172-2024-2025-Q2-1022292
Published purpose
Completion of pharmacokinetic (PK) and pharmacodynamics (PD) studies to provide essential data on how a target drug candidate is processed and delivered to the lung and assessing therapeutic effects.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions